Skip to main content
  • American Heart Association
  • Science Volunteer
  • Warning Signs
  • Advanced Search
  • Donate

  • Home
  • About this Journal
    • Editorial Board
    • Meet the Editors
    • ATVB Journal History
    • General Statistics
  • All Issues
  • Subjects
    • All Subjects
    • Arrhythmia and Electrophysiology
    • Basic, Translational, and Clinical Research
    • Critical Care and Resuscitation
    • Epidemiology, Lifestyle, and Prevention
    • Genetics
    • Heart Failure and Cardiac Disease
    • Hypertension
    • Imaging and Diagnostic Testing
    • Intervention, Surgery, Transplantation
    • Quality and Outcomes
    • Stroke
    • Vascular Disease
  • Browse Features
    • Cover Art Award
    • ATVB Early Career Award
    • ATVB in Focus
    • Recent Brief Reviews of ATVB
    • Lecture Series
    • Collections
    • Recent Highlights of ATVB
    • Commentaries
    • Browse Abstracts
    • Insight into ATVB Authors
  • Resources
    • Instructions for Authors
    • Online Submission/Peer Review Site
    • Council on ATVB
    • Permissions and Rights Q&A
    • AHA Guidelines and Statements
    • Customer Service and Ordering Information
    • Author Reprints
    • International Users
    • AHA Newsroom
  • AHA Journals
    • AHA Journals Home
    • Arteriosclerosis, Thrombosis, and Vascular Biology (ATVB)
    • Circulation
    • → Circ: Arrhythmia and Electrophysiology
    • → Circ: Genomic and Precision Medicine
    • → Circ: Cardiovascular Imaging
    • → Circ: Cardiovascular Interventions
    • → Circ: Cardiovascular Quality & Outcomes
    • → Circ: Heart Failure
    • Circulation Research
    • Hypertension
    • Stroke
    • Journal of the American Heart Association
  • Facebook
  • LinkedIn
  • Twitter

  • My alerts
  • Sign In
  • Join

  • Advanced search

Header Publisher Menu

  • American Heart Association
  • Science Volunteer
  • Warning Signs
  • Advanced Search
  • Donate

Arteriosclerosis, Thrombosis, and Vascular Biology

  • My alerts
  • Sign In
  • Join

  • Facebook
  • LinkedIn
  • Twitter
  • Home
  • About this Journal
    • Editorial Board
    • Meet the Editors
    • ATVB Journal History
    • General Statistics
  • All Issues
  • Subjects
    • All Subjects
    • Arrhythmia and Electrophysiology
    • Basic, Translational, and Clinical Research
    • Critical Care and Resuscitation
    • Epidemiology, Lifestyle, and Prevention
    • Genetics
    • Heart Failure and Cardiac Disease
    • Hypertension
    • Imaging and Diagnostic Testing
    • Intervention, Surgery, Transplantation
    • Quality and Outcomes
    • Stroke
    • Vascular Disease
  • Browse Features
    • Cover Art Award
    • ATVB Early Career Award
    • ATVB in Focus
    • Recent Brief Reviews of ATVB
    • Lecture Series
    • Collections
    • Recent Highlights of ATVB
    • Commentaries
    • Browse Abstracts
    • Insight into ATVB Authors
  • Resources
    • Instructions for Authors
    • Online Submission/Peer Review Site
    • Council on ATVB
    • Permissions and Rights Q&A
    • AHA Guidelines and Statements
    • Customer Service and Ordering Information
    • Author Reprints
    • International Users
    • AHA Newsroom
  • AHA Journals
    • AHA Journals Home
    • Arteriosclerosis, Thrombosis, and Vascular Biology (ATVB)
    • Circulation
    • → Circ: Arrhythmia and Electrophysiology
    • → Circ: Genomic and Precision Medicine
    • → Circ: Cardiovascular Imaging
    • → Circ: Cardiovascular Interventions
    • → Circ: Cardiovascular Quality & Outcomes
    • → Circ: Heart Failure
    • Circulation Research
    • Hypertension
    • Stroke
    • Journal of the American Heart Association
Atherosclerosis/Lipoproteins

Phylloquinone Concentrations and the Risk of Vascular Calcification in Healthy Women

Geertje W. Dalmeijer, Yvonne T. van der Schouw, Sarah L. Booth, Pim A. de Jong, Joline W.J. Beulens
Download PDF
https://doi.org/10.1161/ATVBAHA.114.303853
Arteriosclerosis, Thrombosis, and Vascular Biology. 2014;ATVBAHA.114.303853
Originally published May 22, 2014
Geertje W. Dalmeijer
From the Julius Center for Health Sciences and Primary Care (G.W.D., Y.T.v.d.S., J.W.J.B.) and Department of Radiology (P.A.d.J.), University Medical Center Utrecht, Utrecht, The Netherlands; and Jean Mayer US Department of Agriculture Human Nutrition Research Center of Aging at Tufts University, Boston, MA (S.L.B.).
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yvonne T. van der Schouw
From the Julius Center for Health Sciences and Primary Care (G.W.D., Y.T.v.d.S., J.W.J.B.) and Department of Radiology (P.A.d.J.), University Medical Center Utrecht, Utrecht, The Netherlands; and Jean Mayer US Department of Agriculture Human Nutrition Research Center of Aging at Tufts University, Boston, MA (S.L.B.).
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sarah L. Booth
From the Julius Center for Health Sciences and Primary Care (G.W.D., Y.T.v.d.S., J.W.J.B.) and Department of Radiology (P.A.d.J.), University Medical Center Utrecht, Utrecht, The Netherlands; and Jean Mayer US Department of Agriculture Human Nutrition Research Center of Aging at Tufts University, Boston, MA (S.L.B.).
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Pim A. de Jong
From the Julius Center for Health Sciences and Primary Care (G.W.D., Y.T.v.d.S., J.W.J.B.) and Department of Radiology (P.A.d.J.), University Medical Center Utrecht, Utrecht, The Netherlands; and Jean Mayer US Department of Agriculture Human Nutrition Research Center of Aging at Tufts University, Boston, MA (S.L.B.).
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Joline W.J. Beulens
From the Julius Center for Health Sciences and Primary Care (G.W.D., Y.T.v.d.S., J.W.J.B.) and Department of Radiology (P.A.d.J.), University Medical Center Utrecht, Utrecht, The Netherlands; and Jean Mayer US Department of Agriculture Human Nutrition Research Center of Aging at Tufts University, Boston, MA (S.L.B.).
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Supplemental Materials
  • Info & Metrics
  • eLetters

Jump to

  • Article
  • Supplemental Materials
  • Info & Metrics
  • eLetters
Loading

Abstract

Objective—To investigate the association of plasma phylloquinone concentrations with coronary artery calcification (CAC) and vascular calcification.

Approach and results—In a prospective cohort of 508 postmenopausal women, plasma phylloquinone concentrations were measured by high-pressure liquid chromatography. Calcification was measured in the coronary arteries, aortic valve, mitral valve, and thoracic aorta by multidetector computed tomography. To combine these calcification scores, we dichotomized each of the 4 areas into present or absent. Because of the continuous measurement of CAC, we categorized this as calcification present if Agatston score was >0, and calcification score was calculated as the sum of the calcified areas. Multivariate-adjusted prevalence ratios and odds ratios were estimated using Poisson regression and multinomial logistic regression. After 8.5 years of follow-up, 22% of the women had no calcification, whereas 5% had calcification in all measured areas. Detectable phylloquinone concentrations were associated with increased CAC compared with nondetectable phylloquinone concentrations with a prevalence ratio of 1.34 (95% confidence interval, 1.01–1.77). When dividing women with detectable phylloquinone concentrations into low detectable (>0–0.70 nmol/L) and moderate to high detectable (>0.70 nmol/L) phylloquinone concentrations versus nondetectable phylloquinone concentrations, both were associated with increased CAC with a prevalence ratio of 1.32 (95% confidence interval, 0.99–1.76) and 1.36 (95% confidence interval, 1.02–1.81), respectively. Detectable phylloquinone concentrations were not associated with the number of calcified areas with an odds ratio(no versus ≥3 areas calcifications) of 1.60 (95% confidence interval, 0.65–3.99; P=0.31).

Conclusions—Detectable phylloquinone concentrations are not associated with reduced vascular calcification but seemed to be associated with an increased prevalence of CAC.

  • epidemiology
  • Received December 12, 2013.
  • Accepted May 5, 2014.
  • © 2014 American Heart Association, Inc.
Back to top
Next Article

Current Issue

Arteriosclerosis, Thrombosis, and Vascular Biology
April 2018, Volume 38, Issue 4
  • Table of Contents
Next Article

Jump to

  • Article
  • Supplemental Materials
  • Info & Metrics
  • eLetters

Article Tools

  • Print
  • Citation Tools
    Phylloquinone Concentrations and the Risk of Vascular Calcification in Healthy Women
    Geertje W. Dalmeijer, Yvonne T. van der Schouw, Sarah L. Booth, Pim A. de Jong and Joline W.J. Beulens
    Arteriosclerosis, Thrombosis, and Vascular Biology. 2014;ATVBAHA.114.303853, originally published May 22, 2014
    https://doi.org/10.1161/ATVBAHA.114.303853

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero
  • Article Alerts
    Log in to Email Alerts with your email address.
  • Save to my folders

Share this Article

  • Email

    Thank you for your interest in spreading the word on Arteriosclerosis, Thrombosis, and Vascular Biology.

    NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

    Enter multiple addresses on separate lines or separate them with commas.
    Phylloquinone Concentrations and the Risk of Vascular Calcification in Healthy Women
    (Your Name) has sent you a message from Arteriosclerosis, Thrombosis, and Vascular Biology
    (Your Name) thought you would like to see the Arteriosclerosis, Thrombosis, and Vascular Biology web site.
  • Share on Social Media
    Phylloquinone Concentrations and the Risk of Vascular Calcification in Healthy Women
    Geertje W. Dalmeijer, Yvonne T. van der Schouw, Sarah L. Booth, Pim A. de Jong and Joline W.J. Beulens
    Arteriosclerosis, Thrombosis, and Vascular Biology. 2014;ATVBAHA.114.303853, originally published May 22, 2014
    https://doi.org/10.1161/ATVBAHA.114.303853
    del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo

Related Articles

Cited By...

Subjects

  • Epidemiology, Lifestyle, and Prevention
    • Epidemiology

Arteriosclerosis, Thrombosis, and Vascular Biology

  • About ATVB
  • Instructions for Authors
  • AHA CME
  • Meeting Abstracts
  • Permissions
  • Email Alerts
  • Open Access Information
  • AHA Journals RSS
  • AHA Newsroom

Contact the Editorial Office:
email: atvb@atvb.org

Information for:
  • Advertisers
  • Subscribers
  • Subscriber Help
  • Institutions / Librarians
  • Institutional Subscriptions FAQ
  • International Users
American Heart Association Learn and Live
National Center
7272 Greenville Ave.
Dallas, TX 75231

Customer Service

  • 1-800-AHA-USA-1
  • 1-800-242-8721
  • Local Info
  • Contact Us

About Us

Our mission is to build healthier lives, free of cardiovascular diseases and stroke. That single purpose drives all we do. The need for our work is beyond question. Find Out More about the American Heart Association

  • Careers
  • SHOP
  • Latest Heart and Stroke News
  • AHA/ASA Media Newsroom

Our Sites

  • American Heart Association
  • American Stroke Association
  • For Professionals
  • More Sites

Take Action

  • Advocate
  • Donate
  • Planned Giving
  • Volunteer

Online Communities

  • AFib Support
  • Garden Community
  • Patient Support Network
  • Professional Online Network

Follow Us:

  • Follow Circulation on Twitter
  • Visit Circulation on Facebook
  • Follow Circulation on Google Plus
  • Follow Circulation on Instagram
  • Follow Circulation on Pinterest
  • Follow Circulation on YouTube
  • Rss Feeds
  • Privacy Policy
  • Copyright
  • Ethics Policy
  • Conflict of Interest Policy
  • Linking Policy
  • Diversity
  • Careers

©2018 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. The American Heart Association is a qualified 501(c)(3) tax-exempt organization.
*Red Dress™ DHHS, Go Red™ AHA; National Wear Red Day ® is a registered trademark.

  • PUTTING PATIENTS FIRST National Health Council Standards of Excellence Certification Program
  • BBB Accredited Charity
  • Comodo Secured